Immunohistochemical (IHC) analyses have demonstrated that tumor budding cells (TBC) exhibit molecular traits such as loss of E-cadherin and EpCAM with accumulation of nuclear β-catenin and increased laminin-5γ2, similar to the changes found during EMT [10, 11]. The gene discussed is CDH1; the disease is neoplasm.